Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03878732 · ClinicalTrials.gov registry record
Bindex for Osteoporosis Diagnostics
A clinical trial, sponsored by Bone Index Finland.
- Completed
- Registry status
- 293
- Enrollment target
NCT03878732: Completed study, sponsored by Bone Index Finland.
NCT03878732 is a clinical trial that has completed, run by Bone Index Finland. The registered enrollment target is 293 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03878732 has completed, sponsored by Bone Index Finland.
- COMPLETED
- Registry status
- 293 participants
- Enrollment target
Study Summary
Osteoporosis is a disease that leads to impaired skeletal strength and increased fracture risk. Among 200 million osteoporotic patients most are diagnosed only after several fractures. Furthermore, the progressively aging population will increase the prevalence of osteoporosis. It is estimated that over 75% of osteoporotic patients are not diagnosed and does not receive treatment for their condition. Bindex ultrasound device has been developed and validated in Caucasian female population. In this study, diagnostic thresholds for density index as determined with Bindex will be evaluated in two different ethnic populations.
Primary Outcome
Sensitivity and specificity of DI in caucasian and hispanic groups
Interventions
- DIAGNOSTIC_TEST Bindex measurement
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 293 participants |
| Start Date | 2019-03-11 |
| Est. Completion | 2020-02-07 |
What the finished NCT03878732 record still lists
NCT03878732 is an observational study that tracks outcomes without assigning an intervention. The registered 293 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Bindex measurement is the first listed.
NCT03878732 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03878732 about?
NCT03878732 is a clinical study titled "Bindex for Osteoporosis Diagnostics". Osteoporosis is a disease that leads to impaired skeletal strength and increased fracture risk. Among 200 million osteoporotic patients most are diagnosed only after several fractures. Furthermore, the progressively aging population will increase the prevalence of osteoporosis. It is estimated that ...
What is the current status of trial NCT03878732?
This trial is currently completed. The enrollment target is 293 participants. The study started on 2019-03-11. Estimated completion is 2020-02-07.
What interventions are being tested in trial NCT03878732?
The interventions under investigation include: Bindex measurement (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03878732?
This trial is sponsored by Bone Index Finland, which has 3 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05775159 · 294 participants · Phase 2
Study of Novel Immunomodulators as Monotherapy and in Combination With Anticancer Agents in Participants With Advanced Hepatobiliary Cancer
- NCT06262113 · 294 participants · NA
A Decentralized Clinical Trial to Promote Evidence-Based Care for Underserved Patients With Neurofibromatosis 1
- NCT06338865 · 294 participants · NA
Short Title: Standard vs. Lower Pressure Pneumoperitoneum
- NCT06395467 · 294 participants · NA
Integrated Treatment for Enhancing Growth in Recovery During Adolescence
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI